FDA issued its first warning letter to a dispenser (a medical spa) for violating the Drug Supply Chain Security Act (DSCSA), including failing to source products from authorized trading partners and FDA Moves on Peptides: What Compounding Pharmacies Need to Know I spent 4 months reporting on the peptide BPC 157 and its unlikely journey from a research lab in post communist Croatia to today's MAHA movement. Ask me anything. : r IAmA Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences BPC 157 Banned: Key Facts on the Latest FDA Decision